2m 2m 2m 2m 2m 2m 2m
Madrigal Pharmct (MDGL)
NASDAQ
$516.88+$0.13 (+0.03%)
Price as of Aug 21, 2026 7:30 PM EDT- $11.9BMarket Cap
- 24.61%1-Year Change
- BiotechnologyIndustry
Madrigal Pharmct (MDGL)
$516.88+$0.13 (+0.03%)
MDGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $516.74 | ||
Change | -$2.35 (-0.45%) | ||
Open | $520.09 | ||
High | $530.67 | ||
Low | $514.90 | ||
Previous Close | $519.09 | ||
Volume | 179,832 | ||
30-Day Average Volume | 368,705 | ||
1-Week Change | 1.81% | ||
1-Month Change | -5.50% | ||
1-Year Change | 24.61% | ||
3-Year Change | 188.09% | ||
5-Year Change | 541.75% | ||
Fundamentals | |||
Shares Outstanding | 23.1M | ||
Total Assets | $1.2B | ||
Market Cap | $11.9B | ||
Enterprise Value | $12.0B | ||
Period: QTR TTM FY | |||
Revenue | $364.3M | ||
Net Income | -$57.9M | ||
Free Cash Flow | $19.1M | ||
EBIT | -$57.9M | ||
EBITDA | -$57.6M | ||
Net Working Capital | $825.0M | ||
EPS | -$1.99 | ||
Enterprise Value/EBITDA | -208 | ||
Enterprise Value/Revenue | 33 | ||
P/B | 23 | ||
P/E | -260 | ||
PEG | -7 | ||
Price/Free Cash Flow | 626 | ||
Price/Operating Cash Flow | 512 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 35 | ||
Last Split Date | 07/25/2016 | ||
Earnings & Revenue